Presentation is loading. Please wait.

Presentation is loading. Please wait.

Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas.

Published byἈγλαΐη Σαμαράς Modified over 4 years ago

Similar presentations

Presentation on theme: "Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas."— Presentation transcript:

1 Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas. Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas. A, estrogen receptor α (antibody estrogen receptor α-4) positive in the nucleus of malignant cells and sequencing chromatograms showing the presence of mutant form of EGFR (15-bp deletion in exon 19). Arrow, in-frame deletion mutation sequence. B, estrogen receptor β (antibody estrogen receptor β-1) positive in the nucleus of malignant cells and sequencing chromatograms showing the presence of mutant EGFR (L858R point mutation in exon 21). Arrow, CTG to CGG mutation. C, estrogen receptors α and β (same antibodies than as A and B) with negative expression in the malignant cells and sequencing chromatograms showing the presence of wild-type form of EGFR exon 19. Line, sequences 746 to 750. Maria G. Raso et al. Clin Cancer Res 2009;15: ©2009 by American Association for Cancer Research

Download ppt "Representative examples of estrogen receptor α and β immunohistochemical expression (top figures) and EGFR mutations (bottom figures) in lung adenocarcinomas."

Similar presentations

A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells  Miguel A. Molina-Vila, PhD, Jordi Bertran-Alamillo,

A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells  Miguel A. Molina-Vila, PhD, Jordi Bertran-Alamillo,
Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts Kenichi Suda 1 ;Kenji Tomizawa 2 ;Hiroshi.

Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts Kenichi Suda 1 ;Kenji Tomizawa 2 ;Hiroshi.
Fig. 2. High-resolution melting curves for exon 21 of the EGFR gene

Fig. 2. High-resolution melting curves for exon 21 of the EGFR gene
Figure 3. Representative pyrosequencing results for EGFR gene mutations. (A) Case with 10.9% mutation frequency for the L858R mutation in EGFR exon 21.

Figure 3. Representative pyrosequencing results for EGFR gene mutations. (A) Case with 10.9% mutation frequency for the L858R mutation in EGFR exon 21.
EGFR Mutations in Lung Adenocarcinomas

EGFR Mutations in Lung Adenocarcinomas
Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma  Kazuya Takamochi, MD, Shiaki Oh, MD,

Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma  Kazuya Takamochi, MD, Shiaki Oh, MD,
Enhanced DNA damage in IDH1 mutant glioma cells.

Enhanced DNA damage in IDH1 mutant glioma cells.
Yes, Patient #1 Yes, Patient #3 EGFR sequencing chromatograms

Yes, Patient #1 Yes, Patient #3 EGFR sequencing chromatograms
Mutant EGFR complexes in lung cancer cell lines and immortalized human bronchial epithelial cells. Mutant EGFR complexes in lung cancer cell lines and.

Mutant EGFR complexes in lung cancer cell lines and immortalized human bronchial epithelial cells. Mutant EGFR complexes in lung cancer cell lines and.
EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non–Small Cell Lung Cancer Patients  Irene Yam, BSc, David Chi-Leung Lam, MBBS, PhD, Kaimin.

EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non–Small Cell Lung Cancer Patients  Irene Yam, BSc, David Chi-Leung Lam, MBBS, PhD, Kaimin.
An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients  Ichiro Kawada, MD, Kenzo Soejima, MD, PhD, Hideo.

An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients  Ichiro Kawada, MD, Kenzo Soejima, MD, PhD, Hideo.
Volume 9, Issue 6, Pages (June 2006)

Volume 9, Issue 6, Pages (June 2006)
Detection of EGFR Mutation Status in Lung Adenocarcinoma Specimens with Different Proportions of Tumor Cells Using Two Methods of Differential Sensitivity 

Detection of EGFR Mutation Status in Lung Adenocarcinoma Specimens with Different Proportions of Tumor Cells Using Two Methods of Differential Sensitivity 
Pirh2 promotes p73 ubiquitination in vivo.

Pirh2 promotes p73 ubiquitination in vivo.
A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells  Miguel A. Molina-Vila, PhD, Jordi Bertran-Alamillo,

A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells  Miguel A. Molina-Vila, PhD, Jordi Bertran-Alamillo,
Volume 9, Issue 6, Pages (June 2006)

Volume 9, Issue 6, Pages (June 2006)
Kaplan–Meier curves of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) progression-free survival (PFS) were constructed based on.

Kaplan–Meier curves of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) progression-free survival (PFS) were constructed based on.
Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR  Marie.

Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR  Marie.
Higher Dosage of the Epidermal Growth Factor Receptor Mutant Allele in Lung Adenocarcinoma Correlates with Younger Age, Stage IV at Presentation, and.

Higher Dosage of the Epidermal Growth Factor Receptor Mutant Allele in Lung Adenocarcinoma Correlates with Younger Age, Stage IV at Presentation, and.
Difference in Clonality as a Tool for Differential Diagnosis of Primary Versus Secondary Lung Neoplasms  Giovanni Leuzzi, MD, Alfredo Cesario, MD, Maria.

Difference in Clonality as a Tool for Differential Diagnosis of Primary Versus Secondary Lung Neoplasms  Giovanni Leuzzi, MD, Alfredo Cesario, MD, Maria.

Similar presentations

Ads by Google